US Patent Issued to Intrinsic Medicine on Aug. 12 for "Immunomodulatory oligosaccharides for the treatment of pain" (Washington, California Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,569, issued on Aug. 12, was assigned to Intrinsic Medicine Inc. (Seattle).

"Immunomodulatory oligosaccharides for the treatment of pain" was invented by Alexander Martinez (Des Moines, Wash.) and Jason Ferrone (Fallbrook, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides for methods of treating pain and neuroinflammatory pain conditions with certain oligosaccharides."

The patent was filed on March 25, 2020, under Application No. 17/606,149.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.h...